Replies to post #819986 on NorthWest Biotherapeutics Inc (NWBO)

[DrHigh]

its dilution with no demand. you increase supply and do not address demand you create a downward force on the stock price. its econ 101

[fascinating paradigm]

The demand should increase significantly if and when approval is announced! Many new investors will hear about the positive news, and quite a few of them should join the fray.

[FeMike]

This is to all genuine long this stock, this pull back is orchestrated. There isn’t even the slightest doubt about that.

You are correct, but not for the reason you think you are.

It is orchestrated, yes, but the conductor of this symphony is Linda Powers.

[norisknorewards]

sage007

Re: None

Tuesday, March 31, 2026 1:30:01 PM

Post#
819986
of 819993
This is to all genuine long this stock, this pull back is orchestrated. There isn’t even the slightest doubt about that. And they will keep walking it down in the hope that retail investors get fed up and sell. I suggest that least any one can do, is too hold on till approval decision comes through. Post that too, don’t expect huge improvement in the price. There isn’t short squeeze etc happening. As a matter of fact, even after approval, the MMs and hedgies will keep the price suppressed. Until the stock is uplisted and out of OTC, I am afraid nothing really good is likely to happen. So hang in and

disregard the crap that some people keep posting,

positive and negative crap.

i have an idea...gfys

[norisknorewards]

can you remind me why you created an alias back in 2015, but just decided to start chit posting this month?

[NeWBrO]

Agree 100% , 💯 for the white hats NWBO , in this war !

[hankmanhub]

Post that too, don’t expect huge improvement in the price. There isn’t short squeeze etc happening. As a matter of fact, even after approval, the MMs and hedgies will keep the price suppressed. Until the stock is uplisted and out of OTC, I am afraid nothing really good is likely to happen.

I strongly disagree with parts of your post and your conclusion in particular. I agree that after the uplist there will be less (no) ability to cap the share price at will. But there will definitely be a difference after approval on the OTC as well. Now there are simply no buyers. After the approval there will be many more buyers willing to chase the prize with the nod of approval from the UK. This will make the job of capping the stock much harder and more importantly more expensive and many shorts will not chase a losing short and cover. It will do very well on the OTC despite the shots and yes, do yet better once off the OTC. About the short squeeze, The jury is still out on that one, but no one claims there is a squeeze now. That is silly. But after the MHRA approval, that remains to be seen - It could be something beautiful, or not. You are setting the value of the MAA approval far too short.

[Chiugray]

Sage, I agree with your general sentiment, but there is one thing missing in your equation on the squeeze part. I want to add that existing short positions means the ammunition has already been spent.

What is more powerful, a “wolf pack” of Shorts already holding massive underwater positions (mark-to-market liabilities), or the many brokerages that will force them all to cover at once?

Why? Multiplier effect. Mark-to-market (MTM) liabilities have a multiplier effect. When positions are highly leveraged (especially naked shorts & synthetic short contracts), a 5% collateral means a 20X multiplier effect on price. As MTM losses mount, the pressure to cover becomes an automated loop.

Add Gamma. Gamma is an accelerating, price acceleration effect. When volume spikes, the “days to cover” collapses. This creates a feedback loop accelerating the forcing of market makers to hedge and cover.

After a few days, the brokerages (acting to protect their own balance sheet from the “other side”) will trigger forced liquidations. They will buy NWBO shares on the open market to close out the risk, regardless of price. The Short/MM will simply be charged the bill, automatically.

Whether it’s small scale or large scale, the mechanics are the same. But with large levels of Shorts and especially the synthetic shorts (IMO very likely), that multiplier will turn a mark-to-market liability into a giant financial explosion for them.